The long-term goal of this application is to understand the molecular and cellular mechanisms that govern the migration of neuronal precursors (neuroblasts) in the postnatal mammalian forebrain. These precursors are generated in the forebrain subventricular zone (SVZ) and then migrate via the rostral migratory stream (RMS) to the olfactory bulb (OB) where they join existing circuitries and differentiate into interneurons. Proper migration and integration of newly generated neuroblasts into the OB is important for olfactory learning and plasticity, and, significantly, deficiencies in these processes have been linked to abnormal innate and social behavior. Importantly, neuroblasts are also capable of migrating to sites of injury in the brain, raising the possibility for their use in brain therapies Despite the importance of neuroblast migration, little is known about the molecular mechanisms that regulate this process. We recently uncovered that the DOCK180 family member DOCK7, an activator of Rac, is prominently expressed in neuroblasts in the forebrain of postnatal/adult mice, and importantly that it plays a critical role in neuroblast migration in the RMS. Furthermore, we found that DOCK7 interacts with the schizophrenia-associated ErbB4 tyrosine kinase receptor, which notably was shown to influence RMS neuroblast migration. These findings provide a unique entry point for studying the molecular basis of neuroblast migration in the postnatal forebrain. This application aims to further define DOCK7's role in migrating neuroblasts and identify the molecular pathways DOCK7 is integral to. Towards these goals, Aim 1 will further scrutinize the effects of DOCK7 depletion on the migratory behavior of neuroblasts by performing genetic and live cell imaging experiments. We will also determine the ensuing fate of DOCK7 depleted neuroblasts, taking advantage of a CreER transgenic mouse model and inducible RNAi technology.
Aim 2 will investigate mechanisms of DOCK7 regulation in migrating neuroblasts, with a particular focus on ErbB4, which we postulate is a key regulator of DOCK7 in neuroblast migration. We will test this hypothesis using molecular, genetic and biochemical approaches and will further define DOCK7 regulatory elements important for this interaction and DOCK7 function in neuroblasts. Finally, Aim 3 will characterize molecular mechanisms downstream of DOCK7 in migrating neuroblasts. Our preliminary data suggest that DOCK7 exerts its effects via both Rac-dependent and Rac-independent pathways, each influencing distinct cellular aspects of neuroblast migration. Hence, we will strive to delineate te Rac-mediated signaling pathway(s) involved and identify novel molecular interactions that mediate DOCK7's effects on neuroblast migration, using innovative genetic, molecular and cellular approaches. The proposed studies will provide novel insights into the mechanisms governing postnatal neuroblast migration. As such, they should shed light onto the signaling defects that underlie olfactory deficits and associated CNS disorders, and could aid in the development of novel therapeutic strategies to treat brain injury.
The objective of this application is to understand the molecular and cellular mechanisms that govern the migration of neuroblasts in the postnatal forebrain. Proper migration and integration of neuroblasts in the postnatal forebrain is critical t olfactory learning and plasticity, and occurs at ectopic sites of injury in the CNS. Knowledge gained from these studies is expected to lead to a better understanding of the signaling defects that underlie olfactory deficits and associated CNS disorders, and could aid in the development of novel therapeutic strategies to treat brain injury.
|Nakamuta, Shinichi; Yang, Yu-Ting; Wang, Chia-Lin et al. (2017) Dual role for DOCK7 in tangential migration of interneuron precursors in the postnatal forebrain. J Cell Biol 216:4313-4330|
|Penzo, Mario A; Robert, Vincent; Tucciarone, Jason et al. (2015) The paraventricular thalamus controls a central amygdala fear circuit. Nature 519:455-9|
|Krishnan, Navasona; Krishnan, Keerthi; Connors, Christopher R et al. (2015) PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J Clin Invest 125:3163-77|
|Murray, D W; Didier, S; Chan, A et al. (2014) Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation. Br J Cancer 110:1307-15|
|Tai, Yilin; Janas, Justyna A; Wang, Chia-Lin et al. (2014) Regulation of chandelier cell cartridge and bouton development via DOCK7-mediated ErbB4 activation. Cell Rep 6:254-63|
|Nakano-Kobayashi, Akiko; Tai, Yilin; Nadif Kasri, Nael et al. (2014) The X-linked mental retardation protein OPHN1 interacts with Homer1b/c to control spine endocytic zone positioning and expression of synaptic potentiation. J Neurosci 34:8665-71|
|Anne, Sandrine L; Govek, Eve-Ellen; Ayrault, Olivier et al. (2013) WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation. PLoS One 8:e81769|
|Zhang, Xiaoqun Catherine; Piccini, Antonella; Myers, Michael P et al. (2012) Functional analysis of the protein phosphatase activity of PTEN. Biochem J 444:457-64|
|Kang, Hara; Davis-Dusenbery, Brandi N; Nguyen, Peter H et al. (2012) Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins. J Biol Chem 287:3976-86|
|Yang, Yu-Ting; Wang, Chia-Lin; Van Aelst, Linda (2012) DOCK7 interacts with TACC3 to regulate interkinetic nuclear migration and cortical neurogenesis. Nat Neurosci 15:1201-10|
Showing the most recent 10 out of 15 publications